Healthcare

2026 biotech playbook: Hong Kong at the centre of China’s globalisation

Hong Kong increasingly provides durable, repeat access to capital for public biotech firms.

Hong Kong outlines ‘One plus Three’ model for life and health tech R&D

A headquarters for the Life and Health Technology Research Institutes will be set up.

iX Biopharma secures $52.8m US contract for pain reliever trials

The funding will be allocated for the late-stage development of Wafermine. 

Automation push to fuel 8.5% CAGR in pharma robot market through 2034

The market is estimated to ve valued at $226.24m in 2025.

Ping An Good Doctor projected to see 56% profit CAGR surge by 2027

Ali Health adjusted net profit forecast at 24% CAGR.

Neurocosmetics reshape skincare as 79% favour natural tags

A GlobalData survey showed rising interest in stress-linked skin solutions.

Global respiratory care market to hit $47.9b as AI transforms home treatment

Respiratory care revenue is set to surge as portable oxygen and smart ventilators reach homes.

Radiopharma market to hit $21.8b by 2033 on cancer therapy boom

The Asia-Pacific region is projected to have the highest growth rate.

Medical fibre optics to hit $1.5b by 2030 as minimally invasive surgery surges

The 6.2% CAGR reflects global growth in high-resolution diagnostic fibres and biomedical sensing.